Primary Care Clinics in Montpelier, ID Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Bear Lake Community Health Center-montpelier Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 152 S 4th St, Montpelier, ID 83254 Phone: 208-847-2108 Fax: 208-847-2109 |
Noall E Wolff Md Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 465 Washington St, Montpelier, ID 83254 Phone: 208-847-2878 Fax: 208-847-2340 |
Bear Lake Internal Medicine Internal Medicine Medicare: Medicare Enrolled Practice Location: 166 S 5th St, Montpelier, ID 83254 Phone: 208-847-1110 Fax: 208-847-0228 |
Clay I. Campbell M.d.,p.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 166 S 5th St, Montpelier, ID 83254 Phone: 208-847-3847 Fax: 208-847-1620 |
Bear Lake Family Care And Ob/gyn Family Medicine Medicare: Medicare Enrolled Practice Location: 465 Washington St, Montpelier, ID 83254 Phone: 208-847-4495 Fax: 208-847-4336 |
Bear Lake Family Care And Ob/gyn Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 465 Washington St, Montpelier, ID 83254 Phone: 208-847-4495 |
Health West, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 152 S 4th St, Montpelier, ID 83254 Phone: 208-847-2108 |
News Archive
Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System
Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.
Researchers identify genes that cause resistance to treatment of Candida glabrata fungus
It is estimated that 80% of women will suffer from vaginal candidiasis at least once in their lives. In addition to superficial infections, which can be oral or vaginal and do not usually have a serious prognosis, fungi of the Candida genus can cause systemic diseases in immunocompromised individuals and these are fatal in 40% of cases.
FDA issues Complete Response Letter to Alexza's ADASUVE NDA
Alexza Pharmaceuticals, Inc. announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ADASUVE (loxapine) inhalation powder, 5 mg and 10 mg.
Rates released for Colorado's online insurance marketplace; MNsure launches Paul Bunyan ad campaign
The Wall Street Journal explains to readers about the two types of health exchanges - run either by the state or federal government - which are scheduled to begin operating on Oct. 1. Other news outlets report on developments regarding these marketplaces in Minnesota, Colorado, Alabama, New Mexico, Oregon and Virginia.
Researchers pursuing new approach to treating arthritis
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis.
› Verified 5 days ago